Nutrition Research and Practice

The Korean Nutrition Society (한국영양학회)
권호 표지
DOI QR코드

DOI QR Code

Relationship between 25-hydroxyvitamin D and metabolic syndrome among Jordanian adults

  • Khader, Yousef S. (Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology) ;
  • Batieha, Anwar (Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology) ;
  • Jaddou, Hashim (Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology) ;
  • Batieha, Zahi (King Abdulla University Hospital) ;
  • El-Khateeb, Mohammed (National Center for Diabetes, Endocrinology and Genetics) ;
  • Ajlouni, Kamel (National Center for Diabetes, Endocrinology and Genetics)
  • Received : 2010.09.09
  • Accepted : 2011.03.29
  • Published : 2011.04.28
Download PDF
⟨ Previous Next ⟩

Abstract

Evidence of the association between 25-hydroxyvitamin D (25(OH)D) and metabolic syndrome (MeS) remains uncertain and incongruent. This study aimed to determine the association between 25(OH)D and MeS among Jordanian adults. A complex multistage sampling technique was used to select a national population-based household sample. The present report deals exclusively with adults aged > 18 years who had complete information on all components of MeS (n = 3,234). A structured questionnaire was used to collect all relevant information. Anthropometric, clinical, and laboratory measurements were obtained. MeS was defined according to the International Diabetes Federation (IDF) definition. Of the total, 42.0% had MeS and 31.7% had 25(OH)D < 30 ng/ml. In a stratified analysis, the prevalence of MeS did not differ significantly between subjects with low and normal 25(OH)D levels for men and women in all age groups. In the multivariate analysis, the odds of MeS were not significantly different between subjects with low and normal 25(OH)D levels (OR = 0.85, 95% CI: 0.70, 1.05, P-value = 0.133). The association between 25(OH)D and MeS remained non-significant when 25(OH)D was analyzed as a continuous variable (OR = 1.004, 95% CI; 1.000, 1.008, P = 0.057) and when analyzed based on quartiles. None of the individual components of MeS were significantly associated with 25(OH)D level. This study does not provide evidence to support the association between 25(OH)D level and MeS or its individual components. Prospective studies are necessary to better determine the roles of 25(OH)D levels in the etiology of MeS.

Keywords

References

  1. Calvo MS, Whiting SJ. Prevalence of vitamin D insufficiency in Canada and the United States: importance to health status and efficacy of current food fortification and dietary supplement use. Nutr Rev 2003;61:107-13. https://doi.org/10.1301/nr.2003.marr.107-113
  2. Hanley DA, Davison KS. Vitamin D insufficiency in North America. J Nutr 2005;135:332-7.
  3. Isaia G, Giorgino R, Rini GB, Bevilacqua M, Maugeri D, Adami S. Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int 2003;14:577-82. https://doi.org/10.1007/s00198-003-1390-7
  4. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008;52:1949-56. https://doi.org/10.1016/j.jacc.2008.08.050
  5. Norman AW. Intestinal calcium absorption: a vitamin D-hormonemediated adaptive response. Am J Clin Nutr 1990;51:290-300.
  6. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF. The role of vitamin D in cancer prevention. Am J Public Health 2006;96:252-61. https://doi.org/10.2105/AJPH.2004.045260
  7. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004;80:1717S-20S.
  8. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 2003;17:509-11.
  9. Feskanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004;13:1502-8.
  10. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P. Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control 2000;11:847-52. https://doi.org/10.1023/A:1008923802001
  11. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503-11. https://doi.org/10.1161/CIRCULATIONAHA.107.706127
  12. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008;168:1174-80. https://doi.org/10.1001/archinte.168.11.1174
  13. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-8. https://doi.org/10.1001/jama.296.23.2832
  14. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004;27:2813-8. https://doi.org/10.2337/diacare.27.12.2813
  15. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-29. https://doi.org/10.1210/jc.2007-0298
  16. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49:1063-9. https://doi.org/10.1161/HYPERTENSIONAHA.107.087288
  17. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. https://doi.org/10.2337/diabetes.37.12.1595
  18. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and ${\beta]$ cell dysfunction. Am J Clin Nutr 2004;79:820-5.
  19. Holick MF. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 2002;9:87-98. https://doi.org/10.1097/00060793-200202000-00011
  20. Zemel MB, Hang S, Greer B, Dirienzo D, Zemel PC. Regulation of adiposity by dietary calcium. FASEB J 2000;14:1132-8.
  21. Lee DM, Rutter MK, O'Neill TW, Boonen S, Vanderschueren D, Bouillon R, Bartfai G, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Lean ME, Pendleton N, Punab M, Silman AJ, Wu FC; European Male Ageing Study Group. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol 2009;161:947-54. https://doi.org/10.1530/EJE-09-0496
  22. Bonakdaran S, Varasteh AR. Correlation between serum 25 hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients. Saudi Med J 2009;30:509-14.
  23. Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, Li X, Yang X, Chen Y, Lin X. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009;32:1278-83. https://doi.org/10.2337/dc09-0209
  24. Reis JP, von Mühlen D, Miller ER 3rd. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 2008;159:41-8. https://doi.org/10.1530/EJE-08-0072
  25. Hypponen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008;57:298-305.
  26. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vázquez C, Escobar-Morreale HF. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007;26:573-80. https://doi.org/10.1016/j.clnu.2007.05.009
  27. Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 2002;51:356-9. https://doi.org/10.1053/meta.2002.29969
  28. Kim MK, Kang MI, Oh KW, Kwon HS, Lee JH, Yoon KH, Son HY. The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol (Oxf) 2010;73:330-8.
  29. Maki KC, Rubin MR, Wong LG, McManus JF, Jensen CD, Marshall JW, Lawless A. Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipidol 2009;3:289-96. https://doi.org/10.1016/j.jacl.2009.07.003
  30. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28:1228-30. https://doi.org/10.2337/diacare.28.5.1228
  31. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008;7:4. https://doi.org/10.1186/1475-2891-7-4
  32. Rueda S, Fernandez-Fernandez C, Romero F, Martinez de Osaba J, Vidal J. Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg 2008;18:151-4. https://doi.org/10.1007/s11695-007-9352-3
  33. Reis JP, von Muhlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007;30:1549-55. https://doi.org/10.2337/dc06-2438
  34. Hjelmesaeth J, Hofso D, Aasheim ET, Jenssen T, Moan J, Hager H, Roislien J, Bollerslev J. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol 2009;8:7. https://doi.org/10.1186/1475-2840-8-7
  35. Guerrero-Romero F, Rodriguez-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 2002;39:209-13. https://doi.org/10.1007/s005920200036
  36. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985;10:141-6.
  37. Lee RD, Nieman DC. Nutritional Assessment. 4th ed. New York: McGraw-Hill Higher Education; 2006.
  38. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. June 3-5, 1997. WHO/NUT/NCD/98.1. 1998. p.i-xv, 1-276.
  39. Biosource Europe S.A. [Internet]. 25OH-VIT.D3-RIA-CT. Nivelles; c2011 [cited 2011 March 22]. Available from: http://www.oxfordbiosystems.com/filestore/25OHVitD3RiaKIP1961.pdf.
  40. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome--a new worldwide definition. Lancet 2005;366:1059-62. https://doi.org/10.1016/S0140-6736(05)67402-8
  41. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28.
  42. Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002;112:659-62. https://doi.org/10.1016/S0002-9343(02)01091-4
  43. Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Thomsen J, Charles P, Eriksen EF. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Intern Med 2000;247:260-8. https://doi.org/10.1046/j.1365-2796.2000.00595.x
  44. Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundstrom J, Melhus H, Held C, Lind L, Michaelsson K, Arnlov J. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009;119:2765-71. https://doi.org/10.1161/CIRCULATIONAHA.108.808733
  45. Huerta MG, Roemmich JN, Kington ML, Bovbjerg VE, Weltman AL, Holmes VF, Patrie JT, Rogol AD, Nadler JL. Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 2005;28:1175-81. https://doi.org/10.2337/diacare.28.5.1175
  46. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008;57:2619-25. https://doi.org/10.2337/db08-0593
  47. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007;20:713-9. https://doi.org/10.1016/j.amjhyper.2007.01.017
  48. Judd SE, Nanes MS, Ziegler TR, Wilson PW, Tangpricha V. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2008;87:136-41.
  49. Snijder MB, Lips P, Seidell JC, Visser M, Deeg DJ, Dekker JM, van Dam RM. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 2007;261:558-65. https://doi.org/10.1111/j.1365-2796.2007.01778.x
  50. Hintzpeter B, Mensink GB, Thierfelder W, Müller MJ, Scheidt-Nave C. Vitamin D status and health correlates among German adults. Eur J Clin Nutr 2008;62:1079-89. https://doi.org/10.1038/sj.ejcn.1602825

Cited by

  1. Relationship between Serum 25-hydroxyvitamin D Concentration and the Risks of Metabolic Syndrome in Premenopausal and Postmenopausal Women vol.45, pp.1, 2012, https://doi.org/10.4163/kjn.2012.45.1.20
  2. Absence of Association Between Vitamin D Deficiency and Incident Metabolic Syndrome: Tehran Lipid and Glucose Study vol.11, pp.4, 2013, https://doi.org/10.1089/met.2012.0121
  3. Circulating 25-hydroxyvitamin D levels and hypertension risk vol.28, pp.7, 2013, https://doi.org/10.1007/s10654-013-9817-8
  4. Vitamin D status and its relationship with metabolic syndrome risk factors among adolescent girls in Boukan, Iran vol.17, pp.04, 2014, https://doi.org/10.1017/S1368980013003340
  5. Relationships among Serum Adiponectin, Leptin and Vitamin D Concentrations and the Metabolic Syndrome in Farmers vol.19, pp.1, 2014, https://doi.org/10.5720/kjcn.2014.19.1.12
  6. The relationship between metabolic syndrome and increase of metabolic syndrome score and serum vitamin D levels in Korean adults: 2012 Korean National Health and Nutrition Examination Survey vol.57, pp.1, 2015, https://doi.org/10.3164/jcbn.15-31
  7. 25-hydroxyvitamin D is associated with metabolic syndrome among premenopausal women with systemic lupus erythematosus in China vol.26, pp.4, 2017, https://doi.org/10.1177/0961203316668040
  8. Body composition and metabolic profile in adults with vitamin D deficiency vol.30, pp.4, 2017, https://doi.org/10.1590/1678-98652017000400002
  9. The association between gender difference with metabolic syndrome, metabolic syndrome score and serum vitamin D levels in Korean adults vol.68, pp.1, 2017, https://doi.org/10.1080/09637486.2016.1221899
  10. 한국 폐경기 여성에서 대사증후군과 비타민 D의 관련성: 2010~2012 국민건강영양조사에 근거하여 vol.47, pp.4, 2011, https://doi.org/10.15324/kjcls.2015.47.4.318
  11. Characterizing the type 2 diabetes mellitus epidemic in Jordan up to 2050 vol.10, pp.1, 2020, https://doi.org/10.1038/s41598-020-77970-7
  12. Serum vitamin D levels in relation to abdominal obesity: A systematic review and dose–response meta‐analysis of epidemiologic studies vol.22, pp.2, 2011, https://doi.org/10.1111/obr.13134